Dr Robert Danby, Anthony Nolan's Chief Medical and Scientific Officer, looks ahead to next week’s Graft Selection Strategy Workshop.
The Graft Selection Strategy Workshop
Next week, I have the honour of speaking alongside international colleagues from the USA and Europe about donor selection for haematopoietic cell transplants. Together, we will compare approaches across borders at the annual Graft Selection Strategy Workshop. The science is constantly evolving, at ever-increasing speed, and spreading knowledge and sharing best practice, not just in the UK but around the world, is something we are passionate about at Anthony Nolan.
The latest advances
Exciting advances in haematology and cell therapies mean we have a far broader range of options at our disposal than ever before, and with this increased choice comes increased need for understanding and judgement. Finding a donor for every patient needing a haematopoietic cell transplant remains our goal, but remains incredibly challenging.
However, new therapies and recent changes in transplant practice are bringing new hope to more patients. Post-transplant cyclophosphamide (PTCy), a new treatment used to reduce the risk of complications (graft-versus-host disease) post-transplant, offers a wider range of potential donors to all patients. And umbilical cord blood (UCB) remains a critical source of donor stem cells for patients lacking a suitable adult donor.
Meeting the challenge
But with these recent advances, comes new challenges too. Understanding which genetic (HLA) mismatches between patients and donors are best avoided and which are better tolerated is constantly evolving. So too is our understanding of other important donor factors that influence patient outcome, such as donor age. And crucially, our understanding of donor availability and how we keep our amazing donors engaged and ready to donate when called upon.
So increasingly, with ever more options available, our teams are searching in parallel. We’re looking at multiple donor options at any one time, to find the best possible donor, for that specific patient, at that specific point in time. And with the right treatment and support, to give every patient the best possible chance to survive and thrive.
An opportunity to advance
And so, next week’s Graft Selection Strategy Workshop provides a fantastic opportunity to meet international colleagues and experts in stem cell transplantation and donor selection. To learn from each other, to share common practice and understanding, and to advance our clinical practice and science even further. And, ultimately to improve the chances of survival for every patient that needs a stem cell transplant.
I look forward to seeing you there.